Marquette University

e-Publications@Marquette
Exercise Science Faculty Research and Publications

Exercise Science, Department of

3-1-2011

Association Between the Female Athlete Triad and
Endothelial Dysfunction in Dancers
Anne Z. Hoch
Medical College of Wisconsin

Paula Papanek
Marquette University, paula.papanek@marquette.edu

Aniko Szabo
Medical College of Wisconsin

Michael E. Widlansky
Medical College of Wisconsin

Jane E. Schimke
Medical College of Wisconsin
See next page for additional authors

Accepted version. Clinical Journal of Sport Medicine, Vol. 21, No. 2 (March 2011). DOI: 10.1097/
JSM.0b013e3182042a9a. © 2011 Lippincott Williams & Wilkins, Inc. Used with permission.

Authors

Anne Z. Hoch, Paula Papanek, Aniko Szabo, Michael E. Widlansky, Jane E. Schimke, and David D. Gutterman

This article is available at e-Publications@Marquette: https://epublications.marquette.edu/exsci_fac/22

Association between the Female Athlete Triad and Endothelial Dysfunction
in Dancers
Authors: Anne Z. Hoch, DO, Paula Papanek, PhD, MPT, LAT, Aniko Szabo, PhD, Michael E.
Widlansky, MD, Jane E. Schimke, AAS, and David D. Gutterman, MD

Abstract:
Objective: To determine the prevalence of the 3 components of the female athlete triad
[disordered eating, menstrual dysfunction, low bone mineral density (BMD)] and their
relationships with brachial artery flow-mediated dilation in professional dancers.
Design: Prospective study.
Setting: Academic institution in the Midwest.
Participants: Twenty-two professional ballet dancers volunteered for this study.
Interventions: The prevalence of the female athlete triad and its relationship to
endothelial dysfunction.
Main Outcome Measures: Subjects completed questionnaires to assess disordered
eating and menstrual status/history. They also completed a 3-day food record and wore an
accelerometer for 3 days to determine energy availability. Serum baseline thyrotropin, prolactin,
and hormonal concentrations were obtained. Bone mineral density and body composition were
measured with a GE Lunar Prodigy dual-energy X-ray absorptiometry. Endothelial function was
determined as flow-mediated vasodilation measured by high-frequency ultrasound in the brachial
artery. An increase in brachial diameter <5% to hyperemic flow stimulus was defined a priori as
endothelial dysfunction.
Results: Seventeen dancers (77%) had evidence of low/negative energy availability.
Thirty-two percent had disordered eating (EDE-Q score). Thirty-six percent had menstrual
dysfunction and 14% were currently using hormone contraception. Twenty-three percent had
evidence of low bone density (Z-score < -1.0). Sixty-four percent had abnormal brachial artery
flow-mediated dilation (<5%). Flow-mediated dilation values were significantly correlated with
serum estrogen and whole-body and lumbar BMD. All the 3 components of the triad plus
endothelial dysfunction were present in 14% of the subjects.
Conclusions: Endothelial dysfunction was correlated with reduced BMD, menstrual
dysfunction, and low serum estrogen. These findings may have profound implications for
cardiovascular and bone health in professional women dancers.
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Introduction
There are an estimated 38,000 professional dancers in the United States and countless
amateur or recreational dancers. This unique group of athletes is at high risk for developing the
female athlete triad (triad)1,2 due to the aesthetic nature of the sport.3 The first American College
of Sports Medicine triad position statement was published in 1997 describing the interrelated
conditions of disordered eating, amenorrhea of hypothalamic origin, and osteoporosis. In 2007,
the American College of Sports Medicine revised their position statement on the triad, including
updated recommendations for screening, diagnosis, prevention, and treatment. One new aspect
of the position statement is a comprehensive and expanded definition of each component of the
triad from a spectrum of health to disease, including energy availability (EA) (with or without
disordered eating), menstrual function, and bone health.1 Low/negative EA has been determined
to be the key disorder underlying the relationship to the other components.1,4
The new position statement also includes seminal research from our group that
demonstrated an association between athletic amenorrhea and a reduction in brachial artery
flow-mediated dilation (FMD).1,5 Abnormal brachial dilation has been shown to have a positive
predictive value (95%) for coronary endothelial dysfunction.6 In addition, Schachinger et al7 have
shown that coronary endothelial vasodilator dysfunction predicts long-term atherosclerotic
disease progression and cardiovascular event rates. Therefore, the assessment of brachial
endothelial function can provide valuable information about cardiovascular disease risk in an
otherwise healthy athletic population.
No studies have examined the relationship of all the 3 components of the triad while
simultaneously assessing brachial artery FMD in professional dancers, a high-risk group for the
triad. Therefore, the purpose of this study is to determine the prevalence of the 3 components of
the triad [disordered eating (with/without low/negative EA), menstrual dysfunction, low bone
mineral density (BMD)] and their relationships with brachial artery FMD.

Methods
Subjects and Experimental Design
This study was reviewed and approved by multi-institutional human subjects’ internal
review boards (Medical College of Wisconsin, Marquette University, Milwaukee, Wisconsin).
Inclusion criteria included professional female dancers, aged 18 to 35 years, from a single
company in the Midwest. Exclusion criteria included a history of heart disease, vascular disease,
hypertension, diabetes, hypercholesterolemia, chromosomal disorder, current pregnancy,
pituitary tumor, anomalies of the reproductive system, and thyroid disease. Subjects on a cardiac,
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cholesterol, hypertension, or thyroid medication were excluded. Subjects were not excluded
based on ethnicity. Twenty-two women met the inclusion criteria and completed the study. No
women were excluded based on our criteria. The study was explained in person, and an
informed consent was obtained. Medical histories were obtained by questionnaires and
interview.

Disordered Eating
Energy availability is the amount of dietary energy remaining for other bodily functions
after exercise energy expenditure1,4 and has been demonstrated to be the key in terms of
initiating the neuroendocrine cascade associated with the triad.1,4 Energy intake was determined
from a prospective 3-day food diary recorded during 2 weekdays and 1 weekend day during the
training season. A registered research dietitian met with each dancer for education and training
in proportions or size of food servings, proper recording of foods, and the use of the food diary in
general. Dietary analysis was performed by the research dietician using Nutrition Data System
for Research software version 2007 (developed by the Nutrition Coordinating Center, University
of Minnesota, Minneapolis, Minnesota) to determine total calories, total composition of fat,
protein, carbohydrates, and micronutrient content. Subjects were encouraged to weigh their food
portions for recording.
Estimated energy expenditure during daily exercise was determined by use of an
Actigraph accelerometer (Actigraph GT1M Monitor; Actigraph, Pensacola, Florida).
Accelerometers were individually calibrated for each subject at 2 different self-selected
intensities of exercise with the Cortex metabolic system (Cortex MetaLyzer 3B Version 2.1;
Cortex, Leipzig, Germany). Accelerometers were worn continuously for 72 hours, and the total
kilocalories expended were calculated. Accelerometer has been shown to be a valid device to
measure energy expenditure.8,9
Energy availability was calculated from the subjects’ caloric intake minus the amount of
exercise energy expended over the same time as determined from the accelerometer.
Low/negative EA was defined as a negative value. At the end of the study, each subject met with
the dietician to review her results.
Eating habits and attitudes were assessed by the eating disorder examination
questionnaire (EDE-Q). The EDE-Q is a shorter version of the eating disorder examination10 and
is designed for self-report. The EDE-Q is composed of 4 scales [weight concern, shape concern,
eating concern, dietary restraint] and has a global score or mean composite score of the 4
subscales. Scores ranging from 0 to 6 on a Likert scale correspond to the number of days the

Hoch, Papanek, Szabo, Widlansky, Schimke, Gutterman 3

respondent has experienced a specific attitude, feeling, or behavior during the past 4 weeks.
Athletes were classified as having disordered eating if they had a mean score of ≥4.0 on any
subscale. A cutoff score of 4.0 indicates that a specific attitude or behavior was reported on more
than half of the past 28 days, which was used to define disordered eating because it has been
shown to be predictive of eating disorders.10 Previously, scores of ≥4.0 have been reported to
correspond to the 80th to 95th percentiles from reference norms for adolescent girls.10 Based on
this scoring rubric, athletes were divided into 2 groups: disordered eating (elevated EDE-Q score)
or normal EDE-Q score.

Menstrual Status
Self-administered questionnaires were used to determine age of menarche, number of
periods per year, number of days between periods, skipped periods, history of thyroid disease or
pituitary tumor, and use and type of birth control. A formal interview regarding menstrual status
and medical history was conducted by the principal investigator. For the purpose of this study,
eumenorrhea or regular cycling was defined as menstrual bleeding every 28 to 30 days. Primary
amenorrhea was defined as the absence of menarche by age 15 and secondary amenorrhea as
the cessation of menses for >3 consecutive cycles after onset of menarche. Oligomenorrhea was
represented by menstrual cycles with intervals >35 days.

Hormonal Profiles
To determine the role of reproductive and metabolic hormones and to rule out potential
medical or gynecological causes of amenorrhea, follicle-stimulating hormone, luteinizing
hormone, progesterone, estrogen, thyrotropin, prolactin, and beta-human chorionic gonadotropin
were measured. Hormone concentrations were measured in plasma obtained from whole
venous blood drawn in the early follicular phase of the menstrual cycle (days 4-8) in the early
morning after an 8-hour fast. Amenorrheic dancers followed the same protocol except, since they
were not having menstrual cycles, they were tested at a convenient time. Samples were
processed within hours and kept on ice until transported to the laboratory for analysis. All
measurements were made in a clinical certified laboratory (College of American Pathologists and
Clinical Laboratory Improvement Amendments).

Bone Mineral Density
Each subject underwent BMD measurement by dual-energy X-ray absorptiometry using a
GE Lunar Prodigy densitometer, version 7.52.002 (Madison, Wisconsin). Calibrations with a
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standard phantom spine were performed daily. All measurements were performed by the same
trained professional. The coefficient of variation of the phantom for more than a 6-month period
was 0.29%. Bone mineral density (gram/square centimeter) of the lumbar spine (L1-L4), total left
hip, left femoral neck, left trochanter, and total body were measured for each subject.

Cardiovascular Status
Brachial artery FMD and velocity were determined by techniques previously used in this
laboratory.5 Subjects were studied in a supine resting position after an 8-hour fast in a
temperature-controlled room. Systemic arterial pressure was periodically monitored in the
nondominant arm with an automated sphygmomanometer. Subjects were instrumented for
continuous recording of electrocardiogram, heart rate, and intermittent blood pressure. All
subjects were tested at approximately the same time of day with eumenorrheic subjects studied
in the early follicular phase of the menstrual cycle (days 4-8). Amenorrheic subjects were tested
randomly as scheduled but also in the early morning.

Statistics
The relationship between menstrual status (eumenorrhea, oligomenorrhea, and
amenorrhea) and FMD was evaluated using the nonparametric Jonckheere–Terpstra exact test
for trend after excluding 3 subjects using hormonal birth control. The relationship between
estrogen concentrations and FMD was assessed using Spearman rank correlation for the same
population with an additional exclusion of 1 ovulating subject. Pearson correlation coefficient was
used to determine a correlation among FMD, BMD, and EA.

Results
Subject Characteristics
Twenty-two elite dancers were consented and completed all measurements in this study.
Dancers self-reported their ethnicity as white (n = 20), Asian (n = 1), and Hispanic (n = 1), with a
mean (±SD) age of 23.2 ± 4.7 years. Table 1 provides descriptive demographics of the cohort.

Energy Availability/Disordered Eating
Seventeen dancers (77%) had low/negative EA (-547.8 ± 359.9 kcal/d) (Figure 1A).
Seven dancers (32%) had elevated EDE-Q scores of >4.0 in one or more subcategories,
accounting for a total of 14 elevated scores. Eighty-six percent either had abnormal EDE-Q
scores and/or low/negative EA. Thirteen dancers (59%) were in a calcium deficit (-441.3 ± 347.7
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mg/d) based on a requirement of 1500 mg/d.11 Finally, 10 (46%) were in an iron deficit (mean
deficit of 5.5 mg/d) based on a requirement of 18 mg/d.

Amenorrhea/Oligomenorrhea
Current menstrual status is reported in Figure 1B. Most of the dancers self-reported a
history of menstrual dysfunction. Four (18%) had a history of primary amenorrhea, 14 (64%) had
a history of secondary amenorrhea, and 6 (27%) reported a history of oligomenorrhea. At the
time of the study, 2 dancers were amenorrheic (9%) (2.0 ± 0.1 years) and 6 (27%) were
oligomenorrheic. Collectively, 36% self-reported current menstrual dysfunction. Three (14%)
were taking different forms of combination contraceptive hormones. Beta-human chorionic
gonadotropin tests results were negative. Thyrotropin and prolactin concentrations were within
normal limits.

Bone Mineral Density
The American College of Sports Medicine/World Health Organization (Z-score < -1.0)
criteria are reported (Figure 1C).1,12 Five dancers (23%) had low BMD in 1 or more locations.
International Society for Clinical Densitometry (Z-score < -2.0) criteria were not met by any of our
dancers in any anatomic locations studied.13 Five (23%) had low BMD in the lumbar spine
(L2-L4), 2 (9%) had low whole-body BMD and lumbar spine, and no dancers demonstrated low
BMD in either the left femoral trochanter or left femoral neck. Collectively, 23% had a clinically
significant decrease in BMD at least at 1 site as determined by the dual-energy X-ray
absorptiometry.

Vascular Reactivity
Brachial artery data are summarized in Table 2 and Figure 2. Table 2 includes data on
heart rate, systolic arterial pressure, diastolic arterial pressure, temperature, relative humidity,
baseline brachial artery diameter, FMD, and peak change in flow velocity. Subjects were
subsequently divided into normal and reduced FMD as defined by <5% dilation in response to an
ischemic challenge14,15 and unpublished norms for our laboratory. Brachial artery FMD was
reduced in 14 dancers (64%). Baseline brachial diameters, arterial pressures, resting heart rate,
temperature, humidity, and peak change in flow velocity were not significantly different between
subjects with reduced and with normal FMD.
All subjects with current menstrual dysfunction (n = 8; 36%) had a reduced FMD. A
significant trend was found between menstrual status and FMD (Figure 3A). Amenorrheic
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dancers (n = 2) had a mean FMD of 1.8% ± 0.4. Oligomenorrheic dancers (n = 6) had a mean
FMD of 3.1% ± 1.7%. Five of the eumenorrheic dancers also had a reduced FMD (3.0% ± 1.8%).
A significant difference was found (P = 0.016) for FMD between the amenorrheic group (n = 2)
and total eumenorrheic group (n = 11) (1.8% ± 0.4% vs 5.9% ± 3.0%). Furthermore, lower
estrogen values were associated with significantly lower FMD (P = 0.026) (Figure 3B). Subjects
with the lowest Z-score also had the lowest FMD. The strongest positive correlation (R = 0.50; P
= 0.02) was between FMD and whole-body Z-score (Figures 3C, D). L2 to L4 Z-score also
correlated to FMD (R = 0.46; P = 0.03) (Figure 3C). Interestingly, there was no correlation
between FMD and EA (Figure 3E).

Prevalence of Triad Components
In the present study of elite dancers, 3 (14%) had all the 3 components of the triad and
reduced flow-mediated vasodilation. An additional 5 (23%) had 3 of the 4 components. Three
(14%) had 2 components, 8 (36%) had at least 1 component, and 3 (14%) did not have a single
component.

Discussion
This is the first study to report on the prevalence of all the 3 components of the triad plus
the emerging component of endothelial dysfunction manifested by reduced brachial artery FMD
in professional ballet dancers. The percentage of dancers who met all the 3 components of the
triad and reduced FMD was 14% (3 of 22) with an additional 23% (5 of 22) meeting the criteria
for 3 of the 4 components. This is much higher than that in the study by Torstveit and
Sundgot-Borgen16 of elite Norwegian endurance athletes, where only 4.3% (N = 8) met the
criteria for 3 components of the triad. Although none of those athletes were professional dancers,
6 competed in leanness type sports (running, swimming, biathlon, and bicycling). The prevalence
in our population is also much higher than leanness sports (track, cross-country, and
swimming).18 To previously reported in high school athletes (1%)17,18 from date, the majority of
studies on dancers have looked primarily a variety of sports in which 62% (N = 106) competed in
at the disordered eating or the link between amenorrhea and low BMD,19–21 and none have
investigated the prevalence of endothelial dysfunction. Of the studies specifically designed to
determine the prevalence of all the 3 components of the triad simultaneously, the majority have
focused on elite Norwegian endurance athletes,16,22 college athletes,23 or high school
athletes,17,18 across a spectrum of sports. The prevalence rate of 14% for the triad plus reduced
FMD in elite dancers suggests that the changes in vascular function coexist in sufficient
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frequency that a tetrad of components better describes these athletes.

Flow-Mediated Dilation
No studies have investigated the prevalence of reduced FMD in professional dancers, a
group known to be at high risk for athletic amenorrhea.21,24 Previously, we reported reduced
brachial artery FMD in collegiate runners with amenorrhea (mean FMD, 1.08% ± 0.91).5 Similarly,
Rickenlund et al25 reported a reduced mean FMD of 1.1% in endurance athletes from Sweden.
These results are similar to our amenorrheic (n = 2; mean FMD, 1.8% ± 0.4) and oligomenorrheic
dancers (n = 6; mean FMD, 3.1% ± 1.7) in this study.
The decrease in reactive hyperemic response, although consistent with our previous
work in runners, is surprising. Classically, exercise training enhances endothelium-dependent
vasodilation in peripheral arteries. Elite dancers use both upper and lower extremities for
prolonged periods. However, previous studies26 have shown that elite dancers have a Vo max in
the range of nonendurance athletes. Therefore, the decreased FMD response may be partially
due to suboptimal aerobic fitness. Future studies should measure oxygen consumption directly
to better evaluate this variable.
This study represented a sample of women displaying heterogenous hormonal
disturbances and 3 subjects taking hormone contraceptives. However, all amenorrheic and
oligomenorrheic dancers in this study (8 of 22) had low FMD. Low estrogen concentrations were
correlated with low FMD. However, 5 of the 11 eumenorrheic and the 2 dancers using hormone
contraception also had a reduced FMD, indicating that FMD is not simply a function of circulating
estrogen concentrations. Furthermore, of the 17 subjects with low/negative EA (-547.8 ± 359.9
kcal/d), 71% demonstrated reduced FMD.
These data suggest that endothelial dysfunction is a complex process, which is not solely
determined by estrogen concentrations. It seems that the regulation of flow-mediated
vasodilation, a direct index of endothelial function, may be an integration of menstrual status, and
thus hormone concentrations, aerobic fitness, and EA. Additional nutrient differences may also
play a role but have yet to be investigated. The relationship between menstrual status/estrogen
concentrations and FMD is statistically and clinically relevant. Not only is amenorrhea associated
with reduced BMD but it is also associated with reduced FMD and potentially an increased risk
for cardiovascular disease in otherwise healthy young women.
Three dancers had all 4 components of what we suggest is a tetrad of coexisting
conditions. This is much higher than other studies examining only 3 components of the triad.16–18
We hypothesize that vascular endothelial function is modulated by dietary nutrient content, EA
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(both intake and expenditure), estrogen concentrations, and aerobic condition. The ability to
appropriately vasodilate in response to flow is vital not only for facilitating athletic performance
and recovery but also in terms of vascular health. The high incidence of abnormal brachial artery
FMD is alarming, and additional work is required to determine whether these changes are
predictive of future cardiac and vascular disease because they are in other populations.27 Further
studies are needed to ascertain the relationship of decreased FMD with cardiac function and
human performance as well as underlying mechanisms.
There are several limitations to this study. The sample size is very small, making multiple
comparisons unachievable. However, the major methodological flaw in this study is pooling
statistical analyses of athletes using hormonal contraceptives together with those who are not.
Furthermore, the authors had access to 1 professional dance company, making it difficult to
determine true prevalence. In addition, we had no control group. However, finding age-matched
and body mass index–matched controls proved to be unattainable. Finally, Vo testing would be
valuable to measure because this is a known determinant of FMD.

Conclusions
Our data show that the prevalence of the 4 components (triad and reduced endothelial
function) is comparably high in professional dancers (14%). Abnormal FMD occurred in 64% of
our population. Low FMD was associated with low estrogen concentrations and reduced BMD.
Collectively, this suggests that it is not simply a function of circulating plasma estrogen
concentrations but is more complex and multifactorial. Although additional studies are required to
determine mechanisms, the high incidence of low/negative EA, BMD, and menstrual dysfunction
accentuates target interventions to address this issue in the dance community and raises
concern regarding long-term impact on the vascular system.
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Appendix
Figure 1: Prevalence of the Female Athlete Triad

A. Percentage of dancers with
disordered eating defined as calorie
deficit or abnormal eating disorder
examination questionnaire score.
Calcium deficit based on 1500 mg and
iron deficit based on 18 mg is also
reported.

B. Current menstrual status based on
questionnaire, interview, and blood
work.

C. Bone mineral density in the
dancers. A total of 5 subjects had
reduced bone mineral density (BMD).
Two subjects had reduced BMD in
both the lumbar spine and whole
body.
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Figure 2: Brachial Artery FMD Response to Ischemia

Fourteen dancers had reduced FMD (defined a priori as <5%),14,15 and 8 dancers had normal
FMD.
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Figure 3: Correlations with Flow-Mediated Dilation (FMD)

A. Relationship between menstrual status and FMD. All the subjects with oligomenorrhea and amenorrhea
had abnormal FMD (P = 0.015).
B. Correlation between estrogen concentration (pictogram/milliliter) and FMD. A low estrogen
concentration correlated with a low FMD (P = 0.026).
C. Correlation between lumbar spine (L2-L4) bone mineral density (BMD) and FMD. A low BMD Z-score
correlated with a low FMD (P = 0.033).
D. Correlation between whole-body Z-score and FMD. A low BMD Z-score correlated with a low FMD (P =
0.018).
E. Correlation between energy expenditure (kilocalories) and FMD. There was no correlation between
energy expenditure and FMD (P = 0.52).
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Table 1: Physical Characteristics

Values are mean ± SD unless otherwise indicated.
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Table 2: Brachial Artery Studies

Values are mean ± SD unless otherwise indicated.
FMD, flow-mediated dilation.
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